Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of YH22162 vs Twynsta and Hygroton in Healthy Volunteers
NCT02496910Phase 1Completed
- Sponsor
- Yuhan
- Start
- Jun 2015
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of telmisartan + amlodipine + chlorthalidone in hypertension (HTN) (2 arms), sponsored by Yuhan. Primary endpoints: Maximum Plasma Concentration at 1 month and Area Under the Curve at 1 month. Started Jun 2015; status: completed.
02
Drugs
telmisartan + amlodipine + chlorthalidone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02496910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02496910.